CORONAVIRUS (COVID-19) UPDATE
We are actively implementing measures to protect our employees and customers from COVID-19. Travel restrictions, non-lab essential employee remote work policies, as well as general health procedures are being followed. Our lab remains open and staffed to ensure continuity of service during the pandemic.
Our sophisticated tissue image analysis gives you a distinct advantage in the drug development process
Powered by award-winning, proprietary technology and a multidisciplinary team of experts, Flagship Biosciences brings simplicity to a complicated drug development world.
The Flagship approach:
- Saves time and money in predicting patient response and demonstrating mechanisms of action
- Dramatically improves accuracy
- Accelerates the development process through more robust data
From developing and validating an assay to employing the most comprehensive image analysis data, we provide a full, end-to-end solution for discovering and contextualizing the most relevant endpoints in a CAP/CLIA or RUO setting.
Our approach uses cell-based tissue data, rather than simple pixel data, to provide more accurate information for every sample. Flagship’s unique technology, team, and proven process have reported superior data for hundreds of clinical trials.
Quite simply, we’re changing the drug development paradigm.
Our Services
AI-Powered Image Analysis
Image analysis powered by AI and machine learning, driven by an expert scientific team
IHC / IF / ISH Assays
Discovery, translational research or clinical trials (CAP/CLIA lab)
Data Analysis and Reporting
Standard statistics or data science “deep dives”
Consultation with Scientific Experts
Pathology, biology, image analysis, data science, assay development
Regulatory Strategy and Support
Benefits of Collaborating with Flagship
More accurate and informative tissue data and analytics
Collaboration with our world-renowned scientific team
Increased speed to market for your drug development programs
